Atlas Trials

Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Clinical trial NCT00312598 · COMPLETED

Trial details

NCT number
NCT00312598
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Study type
OBSERVATIONAL
SchizophreniaSchizoaffective DisorderSchizophreniform DisorderMood Disorders
Start date
2005-08-01
Primary completion
2010-04-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.